Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Growth differentiation factor 15"" wg kryterium: Temat


Tytuł:
GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor.
Autorzy:
Guo L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chen Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hu S; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Gao L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tang N; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu R; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Qin Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ren C; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Du S; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2022 Jan; Vol. 28 (1), pp. 158-171. Date of Electronic Publication: 2021 Oct 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glioblastoma*/genetics
Glioblastoma*/immunology
Growth Differentiation Factor 15*/genetics
Growth Differentiation Factor 15*/metabolism
Immunotherapy*
Prognosis*
Tumor Microenvironment*/genetics
Tumor Microenvironment*/immunology
Biomarkers, Tumor/*genetics
Glioma/*genetics
Datasets as Topic ; Humans ; Survival Analysis ; Transcriptome
Czasopismo naukowe
Tytuł:
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
Autorzy:
Yu S; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Li Q; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Yu Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Cui Y; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Li W; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Liu T; Department of Medical Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China. .
Liu F; Department of General Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China. .
Pokaż więcej
Źródło:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Oct; Vol. 69 (10), pp. 1973-1987. Date of Electronic Publication: 2020 May 09.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Neoplasm*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Growth Differentiation Factor 15/*metabolism
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
Macrophages/*immunology
Stomach Neoplasms/*pathology
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Female ; Growth Differentiation Factor 15/genetics ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Macrophages/drug effects ; Macrophages/metabolism ; Macrophages/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Nude ; Signal Transduction ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/immunology ; Stomach Neoplasms/metabolism ; Tumor Cells, Cultured ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Multi-Omics Reveal the Immunological Role and the Theragnostic Value of miR-216a/GDF15 Axis in Human Colon Adenocarcinoma.
Autorzy:
Tung CB; Department of Emergency Medicine, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
Li CY; Department of Surgery, Show Chwan Memorial Hospital, Changhua 500, Taiwan.; Graduate Institute of Biomedical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Lin HY; Research Assistant Center, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Dec 20; Vol. 22 (24). Date of Electronic Publication: 2021 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
Computational Biology*
Adenocarcinoma/*genetics
Colonic Neoplasms/*genetics
Deoxycytidine/*analogs & derivatives
Growth Differentiation Factor 15/*genetics
MicroRNAs/*metabolism
Adenocarcinoma/drug therapy ; Adenocarcinoma/immunology ; Adenocarcinoma/physiopathology ; Antimetabolites, Antineoplastic/therapeutic use ; Apoptosis ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/immunology ; Colonic Neoplasms/physiopathology ; Deoxycytidine/therapeutic use ; Gene Expression Regulation, Neoplastic ; HCT116 Cells ; HEK293 Cells ; Humans ; Mitochondria ; Precision Medicine ; Prognosis ; Gemcitabine
Czasopismo naukowe
Tytuł:
Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Autorzy:
Dai C; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhang X; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Ma Y; Office for Cancer Prevention and Control, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Chen Z; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Chen S; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhang Y; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Li M; Department of Laboratory Diagnostics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Pokaż więcej
Źródło:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2021 Nov; Vol. 26 (7), pp. 598-605. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*blood
Colorectal Neoplasms/*diagnosis
Growth Differentiation Factor 15/*blood
Adult ; Aged ; Colorectal Neoplasms/blood ; Female ; Humans ; Male ; Middle Aged ; Precancerous Conditions/blood ; Precancerous Conditions/diagnosis ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Growth and differentiation factor 15 and NF-κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection.
Autorzy:
Rybicki BA; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.
Sadasivan SM; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.
Chen Y; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.
Kravtsov O; Medical College of Wisconsin, Pathology, Milwaukee, WI, USA.
Palangmonthip W; Medical College of Wisconsin, Pathology, Milwaukee, WI, USA.; Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Arora K; Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.
Gupta NS; Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.
Williamson S; Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.
Bobbitt K; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.
Chitale DA; Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.
Tang D; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Rundle AG; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Iczkowski KA; Medical College of Wisconsin, Pathology, Milwaukee, WI, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 May; Vol. 10 (9), pp. 3013-3025. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*metabolism
Growth Differentiation Factor 15/*metabolism
NF-kappa B p50 Subunit/*metabolism
Prostate/*metabolism
Prostatic Neoplasms/*diagnosis
Black or African American/statistics & numerical data ; Age Factors ; Aged ; Biopsy ; Case-Control Studies ; Confidence Intervals ; Humans ; Kallikreins/blood ; Macrophages/metabolism ; Male ; Middle Aged ; Odds Ratio ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/ethnology ; Regression Analysis ; Risk ; Tumor Suppressor Proteins/metabolism ; White People/statistics & numerical data
Czasopismo naukowe
Tytuł:
Serum macrophage inhibitory cytokine-1 as a clinical marker for non-small cell lung cancer.
Autorzy:
Xu C; Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China.; Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Li L; Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China.; Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Wang W; Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China.; Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Zhang Q; Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China.; Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Zhang X; Department of Respiratory Medicine, Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Yang R; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Mar; Vol. 25 (6), pp. 3169-3172. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Carcinoma, Non-Small-Cell Lung/*blood
Carcinoma, Non-Small-Cell Lung/*diagnosis
Growth Differentiation Factor 15/*blood
Lung Neoplasms/*blood
Lung Neoplasms/*diagnosis
Adult ; Aged ; Carcinoma, Non-Small-Cell Lung/mortality ; Case-Control Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; ROC Curve ; Young Adult
Czasopismo naukowe
Tytuł:
Diagnostic value of macrophage inhibitory cytokine 1 as a novel prognostic biomarkers for early gastric cancer screening.
Autorzy:
Ge X; Department of Laboratory Diagnostics, The First Affiliated Hospital of University of Science and Technology of China, Hefei, P.R. China.
Zhang X; Department of Laboratory Diagnostics, The First Affiliated Hospital of University of Science and Technology of China, Hefei, P.R. China.
Ma Y; Anhui Office for Cancer Control and Research, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P.R. China.
Chen S; Department of Laboratory Diagnostics, The First Affiliated Hospital of University of Science and Technology of China, Hefei, P.R. China.
Chen Z; Department of Laboratory Diagnostics, The First Affiliated Hospital of University of Science and Technology of China, Hefei, P.R. China.
Li M; Department of Laboratory Diagnostics, The First Affiliated Hospital of University of Science and Technology of China, Hefei, P.R. China.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2021 Jan; Vol. 35 (1), pp. e23568. Date of Electronic Publication: 2020 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*blood
Early Detection of Cancer/*statistics & numerical data
Growth Differentiation Factor 15/*blood
Stomach Neoplasms/*diagnosis
Adult ; Female ; Humans ; Male ; Prognosis ; Sensitivity and Specificity ; Stomach Neoplasms/blood ; Stomach Neoplasms/epidemiology
Czasopismo naukowe
Tytuł:
Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Autorzy:
Liu JY; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Dong XX; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Lu JN; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Zhang Y; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Liu KF; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Liu LF; School of Basic Medicine Medical College of Soochow University Suzhou China.
E QZ; School of Basic Medicine Medical College of Soochow University Suzhou China.
Lu XJ; School of Basic Medicine Medical College of Soochow University Suzhou China.
Yin JY; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Shen YP; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases School of Public Health Medical College of Soochow University Suzhou China.
Pokaż więcej
Źródło:
FEBS open bio [FEBS Open Bio] 2018 Nov 28; Vol. 9 (1), pp. 35-42. Date of Electronic Publication: 2018 Nov 28 (Print Publication: 2019).
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Databases, Genetic*
Biomarkers, Tumor/*genetics
Gene Expression Regulation, Neoplastic/*genetics
Growth Differentiation Factor 15/*genetics
Stomach Neoplasms/*genetics
Biomarkers, Tumor/analysis ; Gene Expression Profiling ; Growth Differentiation Factor 15/analysis ; Humans ; RNA, Messenger/genetics ; Stomach Neoplasms/diagnosis
Czasopismo naukowe
Tytuł:
The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.
Autorzy:
Sugimoto M; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Takagi T; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan. .
Konno N; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Suzuki R; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Asama H; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Watanabe K; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Nakamura J; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Waragai Y; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Kikuchi H; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Takasumi M; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Sato Y; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Hikichi T; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Ohira H; Department of Gastroenterology, Fukushima Medical University, School of Medicine, Fukushima, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2017 Aug 23; Vol. 7 (1), pp. 9198. Date of Electronic Publication: 2017 Aug 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Biliary Tract Neoplasms/*diagnosis
Biliary Tract Neoplasms/*metabolism
Growth Differentiation Factor 15/*metabolism
Aged ; Aged, 80 and over ; Diagnosis, Differential ; Female ; Growth Differentiation Factor 15/blood ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; ROC Curve
Czasopismo naukowe
Tytuł:
Growth differentiation factor 15 and its role in carcinogenesis: an update.
Autorzy:
Modi A; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Dwivedi S; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Roy D; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Khokhar M; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Purohit P; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Vishnoi J; Department of Oncosurgery, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Pareek P; Department of Radiotherapy, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Sharma S; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Sharma P; Department of Biochemistry, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Misra S; Department of Oncosurgery, AIIMS Jodhpur, Jodhpur, Rajasthan, India.
Pokaż więcej
Źródło:
Growth factors (Chur, Switzerland) [Growth Factors] 2019 Aug; Vol. 37 (3-4), pp. 190-207. Date of Electronic Publication: 2019 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Biomarkers, Tumor/*metabolism
Carcinogenesis/*pathology
Growth Differentiation Factor 15/*metabolism
Neoplasms/*pathology
Cell Proliferation/physiology ; Drug Resistance, Neoplasm/physiology ; Humans ; Neoplasm Metastasis/pathology ; Neoplasms/diagnosis ; Neovascularization, Pathologic/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis.
Autorzy:
Wang Y; Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, No.24 Jinghua Road, Jianxi District, Luoyang, 471000, China. .
Jiang T; Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, No.24 Jinghua Road, Jianxi District, Luoyang, 471000, China.
Jiang M; Department of Rehabilitation, Seafarers' General Hospital in Heilongjiang Province, Harbin, 150000, China.
Gu S; Department of Clinical Laboratory, The Fifth People's Hospital of Haimen City in Jiangsu Province, Haimen, 226131, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Feb 26; Vol. 19 (1), pp. 177. Date of Electronic Publication: 2019 Feb 26.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Biomarkers, Tumor/*metabolism
Colorectal Neoplasms/*diagnosis
Digestive System Neoplasms/*diagnosis
Growth Differentiation Factor 15/*metabolism
Colorectal Neoplasms/mortality ; Digestive System Neoplasms/mortality ; Humans ; Prognosis ; Proportional Hazards Models ; Survival Analysis
Czasopismo naukowe
Tytuł:
Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
Autorzy:
Traeger L; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, Albert-Schweitzer Campus 1, Building A1, 48149, Muenster, Germany.
Ellermann I; Department of Pharmacy, University Hospital Muenster, University of Muenster, Muenster, Germany.
Wiethoff H; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, Albert-Schweitzer Campus 1, Building A1, 48149, Muenster, Germany.
Ihbe J; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, Albert-Schweitzer Campus 1, Building A1, 48149, Muenster, Germany.
Gallitz I; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, Albert-Schweitzer Campus 1, Building A1, 48149, Muenster, Germany.
Eveslage M; Institute of Biostatistics and Clinical Research, University Hospital Muenster, University of Muenster, Münster, Germany.
Moritz R; Department of Urology, University Hospital Muenster, University of Muenster, Muenster, Germany.; Present Address: Department of Urology, St. Antonius Hospital, Gronau, Germany.
Herrmann E; Department of Urology, University Hospital Muenster, University of Muenster, Muenster, Germany.; Present Address: Department of Urology, Prosper Hospital, Recklinghausen, Germany.
Schrader AJ; Department of Urology, University Hospital Muenster, University of Muenster, Muenster, Germany.
Steinbicker AU; Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, University of Muenster, Albert-Schweitzer Campus 1, Building A1, 48149, Muenster, Germany. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Jan 15; Vol. 19 (1), pp. 74. Date of Electronic Publication: 2019 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*blood
Carcinoma, Renal Cell/*blood
Carcinoma, Transitional Cell/*blood
Growth Differentiation Factor 15/*blood
Hepcidins/*blood
Kidney Neoplasms/*blood
Neoplasm Recurrence, Local/*diagnosis
Ureteral Neoplasms/*blood
Aged ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Carcinoma, Transitional Cell/mortality ; Carcinoma, Transitional Cell/pathology ; Disease Progression ; Female ; Humans ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Ureteral Neoplasms/mortality ; Ureteral Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.
Autorzy:
Wang X
Li Y
Tian H
Qi J
Li M
Fu C
Wu F
Wang Y
Cheng D
Zhao W
Zhang C
Wang T
Rao J
Zhang W; Medical Center for Tumor Detection, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, PR China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2014 Aug 08; Vol. 14, pp. 578. Date of Electronic Publication: 2014 Aug 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*blood
Carcinoma, Pancreatic Ductal/*blood
Growth Differentiation Factor 15/*genetics
Pancreatic Neoplasms/*blood
Aged ; Biomarkers, Tumor/genetics ; CA-19-9 Antigen/blood ; Carcinoma, Pancreatic Ductal/diagnosis ; Carcinoma, Pancreatic Ductal/surgery ; Case-Control Studies ; Female ; Growth Differentiation Factor 15/blood ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
Autorzy:
Yang Y; Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.
Yan S
Tian H
Bao Y
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2018 Mar; Vol. 97 (9), pp. e9994.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Biomarkers, Tumor/*blood
CA-19-9 Antigen/*blood
Growth Differentiation Factor 15/*blood
Pancreatic Neoplasms/*diagnosis
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Odds Ratio ; ROC Curve ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Autorzy:
Hogendorf P; Department of General and Transplant Surgery, Medical University of Lodz, Poland.
Durczyński A; Department of General and Transplant Surgery, Medical University of Lodz, Poland.
Skulimowski A; Department of General and Transplant Surgery, Medical University of Lodz, Poland.
Kumor A; Department of Pulmonology and Allergy, Medical University of Lodz, Poland.
Poznańska G; Department of Anesthesiology and Intensive Care, Medical University of Lodz, Poland.
Strzelczyk J; Department of General and Transplant Surgery, Medical University of Lodz, Poland.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2018 Feb 14; Vol. 21 (3), pp. 505-511.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor*
CA-125 Antigen/*blood
Growth Differentiation Factor 15/*blood
Pancreatic Neoplasms/*blood
Pancreatic Neoplasms/*diagnosis
CA-19-9 Antigen/blood ; Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/diagnosis ; Diagnosis, Differential ; Female ; Humans ; Male ; Pancreatitis, Chronic/blood ; Pancreatitis, Chronic/diagnosis ; ROC Curve
Czasopismo naukowe
Tytuł:
Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
Autorzy:
Vocka M; Department of Oncology, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Langer D; Surgery Department, Second Faculty of Medicine, Charles University, and Military University Hospital in Prague, Prague, Czech Republic.
Fryba V; 1st Department of Surgery - Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Petrtyl J; 4t⁢h Department of Internal Medicine - Department of Gastroenterology and Hepatology, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Hanus T; Department of Urology, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Kalousova M; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Zima T; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Petruzelka L; Department of Oncology, First Faculty of Medicine, Charles University, and General University Hospital in Prague, Prague 2, 128 08, Czech Republic.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2018; Vol. 21 (4), pp. 869-874.
Typ publikacji:
Journal Article
MeSH Terms:
Biomarkers, Tumor/*blood
Colorectal Neoplasms/*pathology
Growth Differentiation Factor 15/*blood
Adult ; Aged ; Area Under Curve ; CA-19-9 Antigen/blood ; Carcinoembryonic Antigen/blood ; Colorectal Neoplasms/blood ; Colorectal Neoplasms/mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; ROC Curve ; Sensitivity and Specificity ; Survival Rate
Czasopismo naukowe
Tytuł:
An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis.
Autorzy:
Windrichova J; 1 Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Kucera R; 1 Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Fuchsova R; 1 Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Topolcan O; 1 Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Fiala O; 2 Department of Oncology and Radiotherapy, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.; 3 Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Svobodova J; 4 Osteocenter, Second Internal Clinic, University Hospital Pilsen, Pilsen, Czech Republic.
Finek J; 2 Department of Oncology and Radiotherapy, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Slipkova D; 1 Department of Immunochemistry, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Pokaż więcej
Źródło:
Technology in cancer research & treatment [Technol Cancer Res Treat] 2018 Jan 01; Vol. 17, pp. 1533033818807466.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*metabolism
Bone Neoplasms/*metabolism
Bone and Bones/*metabolism
Adult ; Aged ; Aged, 80 and over ; Bone Neoplasms/pathology ; Bone Neoplasms/secondary ; Bone and Bones/pathology ; Cohort Studies ; Female ; Growth Differentiation Factor 15/metabolism ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Osteonectin/metabolism ; Radionuclide Imaging/methods
Czasopismo naukowe
Tytuł:
Current and future biomarkers for pancreatic adenocarcinoma.
Autorzy:
Loosen SH; 1 Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Division of GI Oncology, University Hospital RWTH Aachen, Aachen, Germany.
Neumann UP; 2 Department of Surgery, University Hospital RWTH Aachen, Aachen, Germany.
Trautwein C; 1 Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Division of GI Oncology, University Hospital RWTH Aachen, Aachen, Germany.
Roderburg C; 1 Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Division of GI Oncology, University Hospital RWTH Aachen, Aachen, Germany.
Luedde T; 1 Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Division of GI Oncology, University Hospital RWTH Aachen, Aachen, Germany.
Pokaż więcej
Źródło:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2017 Jun; Vol. 39 (6), pp. 1010428317692231.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adenocarcinoma/*genetics
Biomarkers, Tumor/*genetics
CA-19-9 Antigen/*genetics
Pancreatic Neoplasms/*genetics
Adenocarcinoma/diagnosis ; Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Antigens, Neoplasm/genetics ; Biomarkers, Pharmacological ; Equilibrative Nucleoside Transporter 1/genetics ; Growth Differentiation Factor 15/genetics ; Humans ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology ; Prognosis ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Autorzy:
Wang XB; State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiang XR
Yu XY
Wang L
He S
Feng FY
Guo LP
Jiang W
Lu SH
Pokaż więcej
Źródło:
Cancer science [Cancer Sci] 2014 Feb; Vol. 105 (2), pp. 176-85. Date of Electronic Publication: 2014 Jan 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies/*administration & dosage
Biomarkers, Tumor/*blood
Biomarkers, Tumor/*immunology
Carcinoma, Squamous Cell/*metabolism
Carcinoma, Squamous Cell/*therapy
Esophageal Neoplasms/*metabolism
Growth Differentiation Factor 15/*immunology
Animals ; Biomarkers, Tumor/metabolism ; Carcinoma, Squamous Cell/immunology ; Carcinoma, Squamous Cell/pathology ; Cell Line ; Cell Line, Tumor ; Disease Progression ; Esophageal Neoplasms/blood ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/immunology ; Esophageal Neoplasms/pathology ; Esophageal Neoplasms/therapy ; Esophageal Squamous Cell Carcinoma ; Female ; Growth Differentiation Factor 15/blood ; Growth Differentiation Factor 15/metabolism ; Human Umbilical Vein Endothelial Cells ; Humans ; Lymphatic Metastasis ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Neovascularization, Pathologic/blood ; Neovascularization, Pathologic/drug therapy ; Neovascularization, Pathologic/metabolism ; Prognosis ; Random Allocation ; Transcription, Genetic/drug effects ; Up-Regulation/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
Autorzy:
Monteiro-Reis S; Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Genetics, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Leça L; Department of Pathology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Almeida M; Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Genetics, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Antunes L; Department of Epidemiology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Monteiro P; Department of Pathology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Dias PC; Department of Pathology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Morais A; Department of Urology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Oliveira J; Department of Urology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Henrique R; Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Pathology, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira n° 228, 4050-313 Porto, Portugal.
Jerónimo C; Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Genetics, Portuguese Oncology Institute - Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira n° 228, 4050-313 Porto, Portugal. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Jan; Vol. 50 (1), pp. 226-33. Date of Electronic Publication: 2013 Oct 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Biomarkers, Tumor/*urine
Growth Differentiation Factor 15/*genetics
Membrane Proteins/*genetics
Neoplasm Proteins/*genetics
Urinary Bladder Neoplasms/*genetics
Urinary Bladder Neoplasms/*urine
Urothelium/*pathology
Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Female ; Growth Differentiation Factor 15/metabolism ; Humans ; Male ; Membrane Proteins/metabolism ; Middle Aged ; Neoplasm Proteins/metabolism ; Prognosis ; Promoter Regions, Genetic ; Urinary Bladder Neoplasms/pathology ; Urothelium/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies